PhillyPharma Archive: April, 2012

Back on May 7

Comment icon 0 Comments
Phillypharma will be off for a few days, resting fingers. The scheduled return is Monday, May 7. Take care. Read more

Merck profit jumps 67 percent, but overall sales lower than expected

Comment icon 0 Comments
Merck reported a 67 percent profit increase Friday for the first quarter of this year compared to the same period in 2011, despite lower sales... Read more

AstraZeneca CEO David Brennan to depart

Comment icon 0 Comments
AstraZeneca chief executive officer David Brennan said Thursday he would retire June 1 in the wake of another difficult quarter for the pharmaceutical... Read more

GSK profit drops in first quarter

Comment icon 0 Comments
GlaxoSmithKline said Wednesday that first-quarter, after-tax profit dropped about 13 percent compared to the first quarter of 2011. The global... Read more

Pfizer, AstraZeneca make deals

Comment icon 0 Comments
Pfizer and AstraZeneca both made deals official Monday morning. Pfizer said early Monday morning that it has entered an agreement to sell... Read more

Merck Vioxx fines reach $950 million

Comment icon 0 Comments
Merck was fined $321,636,000 Thursday by U.S. District Court Judge Patti B. Saris in Boston after pleading guilty in December to one misdemeanor... Read more

Glaxo offers $2.6 billion for Human Genome Sciences

Comment icon 0 Comments
Biotech drugmaker Human Genome Sciences, Inc., said Thursday morning that it received an unsolicited takeover proposal from GlaxoSmithKline... Read more

J&J gets European approval for Synthes purchase

Comment icon 0 Comments
The European Commission announced Thursday morning that it had approved Johnson & Johnson's $21.3 billion purchase of medical device manufacturer... Read more